L-, N- and T-type Ca2+ channel inhibitor (IC50 = 2.7 nM for ICa inhibition). Inhibits the activation of aldosterone-induced mineralocorticoid receptor. Shows anti-atherosclerotic, antihypertensive and cardioprotective actions.
Mechanisms of long-lasting effects of benidipine on Ca current in guinea-pig ventricular cells.
Yamamoto M et al (1990) Br J Pharmacol 100(4) : 669-76.
Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker.
Yao K et al (2006) J Pharmacol Sci 100(4) : 243-61.
The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family.
Kosaka H et al (2010) Eur J Pharmacol 635(1-3) : 49-55.